Latest filing published 29 Dec 2022 for Zhongzhi Pharmaceutical Holdings Ltd.. Read the official filing
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Cao Xiao Jun on record concern Zhongzhi Pharmaceutical Holdings Ltd. The record holds 7 filings, for trades running from 28 March 2022 to 28 December 2022.
Every open-market trade on record is a purchase: 7 purchases worth €74k, and no sale. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
In size, the median ticket on the buying side is €8,584. 3 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. After 6 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +9.6%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 29 December 2022 with an open-market purchase in Zhongzhi Pharmaceutical Holdings Ltd. Typically, a trade is published a median of 1 day after it takes place. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations